RxDoctor Payments Data

Megan Church, DO

Family Medicine · Warren, PANPI 1902366958

Payments from drug & device makers

$846in general payments, 2019–2025

Across 49 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$122
  • Amgen$117
  • Bayer$99
  • Exact Sciences$99
  • Novo Nordisk$61
  • Pfizer$58
  • plus $290 from 13 others

What the payments were for

  • Food & beverage$846100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$846 in reported general payments places this provider in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$52,284
Medicare patients
328
Services billed
545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban80$83,519
EliquisApixaban48$63,997
OzempicSemaglutide17$27,841
JanuviaSitagliptin Phosphate18$25,557
TrulicityDulaglutide12$18,137
MounjaroTirzepatide14$14,708
Breo ElliptaFluticasone/Vilanterol17$10,573
Atorvastatin Calcium355$4,499
Fluticasone-SalmeterolFluticasone Propion/Salmeterol34$4,262
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,824
Lisinopril364$3,164
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,022
Allopurinol103$3,015
Levothyroxine Sodium289$2,781
Pantoprazole Sodium159$2,535

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$63,99748 claims
Novo NordiskOzempic$61$27,84117 claims
GSKBreo Ellipta$35$10,57317 claims
AbbVieSynthroid$15$1,48148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Warren

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →